As of 2024-12-15, the Fair Value of Cullinan Oncology Inc (CGEM) is -12.33 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 11.75 USD, the upside of Cullinan Oncology Inc is -204.90%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -20.66 | -51.80 | -65.57 | 111.21 | -153.16 | -36.00 |
| YoY growth | -45.60% | -150.73% | -26.58% | 269.61% | -237.72% | -38.20% |
| Market Cap (mil) | 684.20 |
| P/E | |
| Forward P/E |
| EPS | -2.47 |
| Avg earnings growth rate | -38.20% |
| TTM earnings | -143.54 |